Pleural Dynamics today announced positive results from a prospective, multicenter study evaluating its ACES device.

AtriCure (Nasdaq:ATRC) announced the first patient enrolled in its BoxX-NoAF clinical trial evaluating its cardiac therapy ...

Orchestra BioMed (Nasdaq:OBIO) announced today that it entered into a termination and right of first refusal agreement with ...

Abbott (NYSE: ABT) reported new study findings supporting the use of its Tendyne transcatheter mitral valve replacement (TMVR ...

Zimmer Biomet (NYSE: ZBH) announced that it received FDA breakthrough device designation for its iodine-treated total hip ...

Remedy Robotics has entered a strategic partnership with the Society of Vascular and Interventional Neurology’s Mission ...

Edwards Lifesciences (NYSE: EW) today shared new data demonstrating successful outcomes with its mitral and tricuspid ...

Medtronic (NYSE: MDT) today announced the first results from the high cardiovascular risk cohort of its SPYRAL AFFIRM study.

Edwards Lifesciences (NYSE: EW) today announced new data demonstrating long-term benefits with its Sapien heart valve system.

Elixir Medical today announced new landmark clinical results for its DynamX bioadaptor coronary implant system.

The study found that the use of the company’s computer-assisted vacuum thrombectomy (CAVT) system, a form of mechanical ...

Boston Scientific also reported findings from the ALLIANCE registry looking at 1,800 Agent patients in Japan. It assessed the ...